Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Collaborative Research Partnership (Partnering PI Option)

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract establishes a collaborative research partnership where a Partnering Principal Investigator from an external institution will co-lead the research effort alongside the primary team, sharing equal responsibility for scientific direction, project management, and deliverables. Funding is jointly allocated between the participating institutions, ensuring aligned resources and mutual accountability for outcomes, with the work focused on health-related research under the Defense Health Agency Contracting Activity. The initiative falls under NAICS code 541711, indicating it is within the scientific research and development sector, and is structured as a subcontract to support integrated, multi-institutional innovation. The opportunity was posted on June 18, 2026, with a deadline for responses set for September 28, 2026, providing potential partners a defined window to submit proposals. The partnership is expected to be conducted in alignment with the mission of the Department of Defense, addressing critical health priorities through joint scientific leadership. There is no set-aside designation specified, meaning eligibility is open to qualified institutions regardless of size or status, and no specific location is designated for performance, allowing flexibility in where the research activities are carried out as long as the objectives are met collaboratively.

General Info

Collaborative health research partnership with shared leadership, funding, and no location or size restrictions under Defense Health Agency.

Agency

Department Of Defense → Defense Health Agency Contracting Activity - DhacaView Agency

NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency Contracting Activity - Dhaca
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → Defense Health Agency Contracting Activity - Dhaca
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Serve as a Partnering Principal Investigator from a separate institution, co-leading the research with shared funding and responsibilities.

Similar Contracts

NAICS: 541711
New
Grant
Kidney Cancer Clinical Research ExecutionThe contract titled Kidney Cancer Clinical Research Execution aims to advance clinical and translational research focused on kidney cancer through comprehensive scientific activities including study design, patient data collection, biomarker analysis, and therapeutic development. The work is intended to support the development of innovative treatments and diagnostic strategies by integrating clinical observations with laboratory research, ensuring findings are rapidly translated into improved patient outcomes. The project requires expertise in oncology research methodologies, rigorous data management, and interdisciplinary collaboration to address critical gaps in kidney cancer understanding and care. This subcontract is issued by the Defense Health Agency Contracting Activity under the Department of Defense and falls under NAICS code 541711, indicating it is related to research and development in the life sciences. The opportunity was posted on June 18, 2026, with a response deadline of September 28, 2026, providing potential applicants approximately three months to prepare and submit proposals. The place of performance and specific office address details are not specified, suggesting flexibility in location but requiring proposers to align with the overarching objectives of the Department of Defense’s medical research priorities. All work must demonstrate scientific excellence, feasibility, and direct relevance to advancing kidney cancer therapeutics within a clinical context.
Defense Health Agency Contracting Activity - Dhaca

POSTED

2 days ago

DEADLINE

in 3 months
View Details
NAICS: 541711
New
Federal
Expanded Viral Respiratory Disease SurveillanceThe contract aims to expand surveillance efforts for complications arising from influenza and other viral respiratory diseases specifically in pediatric populations, going beyond the initial focus on influenza-associated encephalopathy. This initiative seeks to enhance data collection, analysis, and reporting to better understand the scope and impact of these infections among children, informing public health responses and intervention strategies. The work will involve coordinated surveillance systems, likely including clinical, laboratory, and epidemiological components, to capture a broader range of respiratory pathogens and their associated complications in real time. The subcontract is issued by the CDC Office of Acquisition Services under the U.S. Department of Health and Human Services with a NAICS code of 541711, indicating it involves research and development in the physical, engineering, and life sciences. The place of performance is designated as 02115, pointing to a location in Boston, Massachusetts. The solicitation was posted on June 18, 2026, with a firm response deadline of July 2, 2026, at 6:00 PM Eastern Time. Although details about the specific awardee, point of contact, or set-aside status are not provided, the emphasis is on building a comprehensive, scalable surveillance infrastructure focused on children’s health outcomes linked to viral respiratory illnesses.
CDC Office Of Acquisition Services

POSTED

2 days ago

DEADLINE

in 12 days
View Details